Fluorescent cytochemical oestrogen receptor assay: is it valid in breast cancer?
C M Furnival, K C Chong, L R Watson, A Visona
Index: Br. J. Surg. 70(8) , 457-9, (1983)
Full Text: HTML
Abstract
The performance of a fluorescent cytochemical oestrogen receptor (ER) assay has been compared with an established dextran-coated charcoal ER assay in 85 cases of primary breast cancer. Both assays were performed on tissue samples from the same tumour, by independent observers in different laboratories. A good qualitative correlation between the two methods was found, with agreement in 92 per cent of cases (P less than 0.0005). Criticisms of the fluorescein-labelled oestrogen methods are discussed. It is concluded that such methods should be validated in each laboratory by comparison with a conventional, quantitative ER assay before being used for clinical decisions.
Related Compounds
Related Articles:
A convenient homogeneous enzyme immunoassay for estradiol detection.
2011-01-01
[Biotechnol. Appl. Biochem. 58(1) , 75-82, (2011)]
Histochemical estrogen receptor assay.
1981-09-01
[Am. J. Clin. Pathol. 76(3) , 365, (1981)]
1982-01-01
[Virchows Arch.,. B, Cell Pathol. 40(1) , 27-37, (1982)]
1986-05-01
[J. Steroid Biochem. 24(5) , 1017-31, (1986)]
2012-03-01
[Zhonghua Fu Chan Ke Za Zhi 47(3) , 212-7, (2012)]